FSSAI

FSSAI direction: Regarding misleading advertisement and marketing of ORS substitute products

On 8th April 2022, FSSAI issued a direction regarding misleading advertisement and marketing of ORS substitute products. The product ‘ORS’ is a Drug under Drugs and Cosmetics Rules 1945 which is used for the treatment of acute diarrhoea and has a specific composition prescribed by the Drugs Controller General of India (DCGI). Therefore, it is clarified that the use of the term ‘ORS’ or similar to ‘ORS’ on food product labels or through advertisement is not allowed under FSSRs and use of such terms may render the products as Misbranded Food, under Sec.3 of FSS Act.

Read the direction here.